Vyvanse shortage ‘resolved’

TGA declares supply issues impacting ADHD medication Vyvanse to be “resolved”  Takeda Pharmaceuticals Australia is reporting that supply shortages are no longer impacting its Vyvanse (lisdexamfetamine dimesilate) capsules.  Shortages had impacted various strengths of the medication, with the Therapeutic Goods Administration (TGA) reporting that supplies of Vyvanse 50mg capsules had been resolved as of 7 March,